A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

NCT06672939 · PHASE3 · RECRUITING · Sponsor: Eli Lilly and Company · Conditions: Obesity,

By Priya Raman · Science Reporter

Nov 4 07:00 ETSource: ClinicalTrials.gov

From the source

A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
NCT06672939 · PHASE3 · RECRUITING · Sponsor: Eli Lilly and Company · Conditions: Obesity, Overweight.

Read at clinicaltrials.gov

Source URL https://clinicaltrials.gov/study/NCT06672939